Phenotype Restricted Genome-Wide Association Study Using a Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma Susceptibility Loci
暂无分享,去创建一个
Joseph T. Glessner | J. Glessner | H. Hakonarson | Cecilia Kim | Kai Wang | K. Cole | M. Devoto | J. Maris | S. Diskin | A. Iolascon | E. Attiyeh | M. Diamond | Y. Mossé | M. Capasso | L. Nguyễn | Hongzhe Li
[1] Nazneen Rahman,et al. Integrative genomics identifies LMO1 as a neuroblastoma oncogene , 2011, Nature.
[2] Mary Goldman,et al. The UCSC Genome Browser database: update 2011 , 2010, Nucleic Acids Res..
[3] J. Maris. Recent advances in neuroblastoma. , 2010, The New England journal of medicine.
[4] Sharon J. Diskin,et al. Copy number variation at 1q21.1 associated with neuroblastoma , 2009, Nature.
[5] J Khan,et al. International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee , 2009, British Journal of Cancer.
[6] Nazneen Rahman,et al. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma , 2009, Nature Genetics.
[7] Nazneen Rahman,et al. Chromosome 6p22 locus associated with clinically aggressive neuroblastoma. , 2008, The New England journal of medicine.
[8] Giorgio Valle,et al. The Gene Ontology project in 2008 , 2007, Nucleic Acids Res..
[9] Jill P. Mesirov,et al. GSEA-P: a desktop application for Gene Set Enrichment Analysis , 2007, Bioinform..
[10] J. Khan,et al. 181 INVITED International consensus for neuroblastoma molecular diagnostics: report from the international neuroblastoma risk grouping (INRG) biology committee , 2007 .
[11] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[12] M. Newton,et al. Random-set methods identify distinct aspects of the enrichment signal in gene-set analysis , 2007, 0708.4350.
[13] Terrence S. Furey,et al. The UCSC Genome Browser Database: update 2006 , 2005, Nucleic Acids Res..
[14] Jelle J. Goeman,et al. A global test for groups of genes: testing association with a clinical outcome , 2004, Bioinform..
[15] K K Matthay,et al. The International Neuroblastoma Pathology Classification (the Shimada system) , 1999, Cancer.
[16] F. Berthold,et al. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. , 1993, Progress in clinical and biological research.
[17] A T Look,et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] H. Varmus,et al. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. , 1984, Science.
[19] N. Breslow,et al. Statistical estimation of prognosis for children with neuroblastoma. , 1971, Cancer research.